Literature DB >> 33949208

Lung metabolomics after ischemic acute kidney injury reveals increased oxidative stress, altered energy production, and ATP depletion.

Sophia L Ambruso1,2, Hyo-Wook Gil3, Benjamin Fox2, Bryan Park2, Christopher Altmann2, Rushita A Bagchi2, Peter R Baker2, Julie A Reisz2, Sarah Faubel1,2.   

Abstract

Acute kidney injury (AKI) is a complex disease associated with increased mortality that may be due to deleterious distant organ effects. AKI associated with respiratory complications, in particular, has a poor outcome. In murine models, AKI is characterized by increased circulating cytokines, lung chemokine upregulation, and neutrophilic infiltration, similar to other causes of indirect acute lung injury (ALI; e.g., sepsis). Many causes of lung inflammation are associated with a lung metabolic profile characterized by increased oxidative stress, a shift toward the use of other forms of energy production, and/or a depleted energy state. To our knowledge, there are no studies that have evaluated pulmonary energy production and metabolism after AKI. We hypothesized that based on the parallels between inflammatory acute lung injury and AKI-mediated lung injury, a similar metabolic profile would be observed. Lung metabolomics and ATP levels were assessed 4 h, 24 h, and 7 days after ischemic AKI in mice. Numerous novel findings regarding the effect of AKI on the lung were observed including 1) increased oxidative stress, 2) a shift toward alternate methods of energy production, and 3) depleted levels of ATP. The findings in this report bring to light novel characteristics of AKI-mediated lung injury and provide new leads into the mechanisms by which AKI in patients predisposes to pulmonary complications.

Entities:  

Keywords:  acute kidney injury; glutathione; inflammatory lung injury; metabolomics; organ cross talk

Year:  2021        PMID: 33949208     DOI: 10.1152/ajplung.00042.2020

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  2 in total

1.  Chrysosplenol D protects mice against LPS-induced acute lung injury by inhibiting oxidative stress, inflammation, and apoptosis via TLR4-MAPKs/NF-κB signaling pathways.

Authors:  Qinqin Zhang; Aozi Feng; Mengnan Zeng; Beibei Zhang; Jingya Shi; Yaxin Lv; Bing Cao; Chenxin Zhao; Mengya Wang; Yifan Ding; Xiaoke Zheng
Journal:  Innate Immun       Date:  2021-11-20       Impact factor: 2.680

2.  Editorial: Kidney and Distant Organ Crosstalk in Health and Disease.

Authors:  Natalia López-Andrés; Frederic Jaisser; Jonatan Barrera-Chimal
Journal:  Front Physiol       Date:  2021-07-01       Impact factor: 4.566

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.